Plasma LPA and its Edg-2/Edg-7 receptor might be therapeutic targets for treating ovarian malignant tumor.

• 结论:血浆LPA及其受体Edg-2/Edg-7可能成为治疗卵巢恶性肿瘤的新靶点。